Goldman Sachs Downgrades Humana (HUM) to Neutral

Goldman Sachs downgraded Humana (NYSE: HUM) from Buy to Neutral with a price target of $90 (down from $98).

The firm sees more upside in others areas of their coverage. Specifically, the firm's Buy-rated names in managed care include Health Net (NYSE: HNT), Coventry (NYSE: CVH), and WellCare (NYSE: WCG).

For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.

Shares of Humana closed at $81.39 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• OPT Machine Vision Tech Co Ltd (688686:CH) PT Raised to RMB147.60 at Macquarie